Plan for patologitjenester i Helse Vest 2004
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype. - Abstract - Europe PMC
The thalamus and its subnuclei—a gateway to obsessive-compulsive disorder | Translational Psychiatry
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration - Kråkenes - 2019 - Annals of Neurology - Wiley Online Library
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype. - Abstract - Europe PMC
Forskingsmidler frå Helse Vest til tverrfagleg forsking hos Neuro-SysMed | Neuro-SysMed (NSM) | UiB
Forskningshåndboka 5. utg.pdf - Helse Vest
Tinne Amalie Damgaard Nissen (@TinneNissen) / Twitter
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
Helse Vests forskningsmidler - informasjonsmøter august 2016
Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration - Kråkenes - 2019 - Annals of Neurology - Wiley Online Library
Tildeling av Helse Vests forskingsmidlar 2023 - Helse Vest RHF
Tildeling av Helse Vests forskingsmidlar 2017 - Helse Stavanger
Tildeling av Helse Vests forskingsmidlar 2022 - Helse Vest RHF
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype - ScienceDirect
Correlation of Blood T-Cells to Intratumoural Density and Location of CD3+ and CD8+ T-Cells in Colorectal Cancer | Anticancer Research
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype - ScienceDirect
KLINISK INSTITUTT 1 Helse Vest-søknader og semesterstart KLINISK INSTITUTT 1
Tildeling av Helse Vests forskingsmidlar 2023 - Helse Vest RHF
Nyttig informasjon
gjennomslag-i-nasjonal-helse-og-sjukehusplan
Forside - Sykehusinnkjøp
Nå får ansatte på sykehus koronatillegg
Viderefoerte stipend - Helse Vest
